AMPH vs IRM · P/E 12, rev $732.0M vs P/E 136, rev $6.15B
Amphastar P (AMPH) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the AMPH and IRM stock pages for the full models.
Not investment advice.